When it comes to treatment considerations for breast cancer, several factors are taken into account, including the expression of HER2, progesterone receptor (PR), and estrogen receptor (ER), along with other patient- and tumor-specific characteristics. This evidence concerns the gene ERBB2 and breast cancer.